Food and Drug Regulation in an Era of Globalized Markets
Editat de Sam F Halabien Limba Engleză Paperback – 10 sep 2015
From the changing nature of packaged and processed food supply chains, to the reorientation of pharmaceutical research and funding coalesced to confront firms, regulators, and consumers are now faced with previously unknown challenges.
Based on the 2014 O’Neill Institute Summer program, this book provides an international, cross-disciplinary look at the changing world of regulations and offers insights into requirements for successful implementation.
- Interdisciplinary approach allows readers to understand the varying perspectives involved in regulatory development
- Includes case studies to highlight harmonization efforts and challenges, and to provide practical insights for application going forward
- Provides a thorough assessment of supply chains, potential gaps, and means of anticipating and addressing issues
- Presents a comprehensive snapshot of changes in the food safety law in the United States and under international standards, including academic, industry and regulatory perspectives
- Addresses conflicts and cooperation between relevant US agencies including USDA, FDA, DEA, EPA, FTC and the Department of Commerce
Preț: 604.26 lei
Preț vechi: 793.21 lei
-24% Nou
Puncte Express: 906
Preț estimativ în valută:
115.64€ • 120.12$ • 96.06£
115.64€ • 120.12$ • 96.06£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128023112
ISBN-10: 0128023112
Pagini: 264
Ilustrații: black & white illustrations
Dimensiuni: 152 x 229 x 14 mm
Greutate: 0.35 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128023112
Pagini: 264
Ilustrații: black & white illustrations
Dimensiuni: 152 x 229 x 14 mm
Greutate: 0.35 kg
Editura: ELSEVIER SCIENCE
Public țintă
Academics and regulators from a wide range of low- middle- and high-income countries; legal professionals who mainly work in the food and drug regulatory space for North American and European firms who are increasingly accessing low- and middle-income markets for a number of reasons; and, managers in major food and drug firms seeking to understand the next set of regulatory challenges ahead.Cuprins
- Foreword;
- Introduction;
- Part I: Convergence and Divergence in Regulatory Regimes;
- Part II: Challenges Accompanying the Globalization of Pharmaceutical Supply Chains;
- Part III: Challenges Accompanying the Diversification and Globalization of Food Sources and Additives;
- Part iv: Challenges in Emerging and Middle Income Markets